The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | Common | 004225108 | 19,243 | 581,900 | SH | SOLE | 581,900 | 0 | 0 | ||
AEGERION PHARMACEUTICALS INC | Common | 00767E102 | 10,966 | 806,300 | SH | SOLE | 806,300 | 0 | 0 | ||
AGENUS - INC | Common | 00847G705 | 10,116 | 2,199,137 | SH | SOLE | 2,199,137 | 0 | 0 | ||
ALLIQUA BIOMEDICAL INC | Common | 019621200 | 2,695 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 59,460 | 4,250,199 | SH | SOLE | 4,250,199 | 0 | 0 | ||
AXOVANT SCIENCES LTD. | Common | G0750W104 | 5,252 | 406,470 | SH | SOLE | 406,470 | 0 | 0 | ||
CATALYST BIOSCIENCES INC. | Common | 14888D109 | 391 | 83,901 | SH | SOLE | 83,901 | 0 | 0 | ||
CELLECTIS - ADR | Sponsored ADS | 15117K103 | 923 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
DERMIRA INC | Common | 24983L104 | 8,478 | 363,250 | SH | SOLE | 363,250 | 0 | 0 | ||
EGALET CORPORATION. | Common | 28226B104 | 5,807 | 440,606 | SH | SOLE | 440,606 | 0 | 0 | ||
FORTRESS BIOTECH INC. | Common | 34960Q109 | 3,316 | 1,275,521 | SH | SOLE | 1,275,521 | 0 | 0 | ||
HEAT BIOLOGICS INC | Common | 42237K102 | 1,576 | 341,064 | SH | SOLE | 341,064 | 0 | 0 | ||
HERON THERAPEUTICS INC | Common | 427746102 | 128 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
HERON THERAPEUTICS INC | Common | 427746102 | 25 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
IGI LABORATORIES INC | Common | 449575109 | 11,640 | 1,779,782 | SH | SOLE | 1,779,782 | 0 | 0 | ||
INNOCOLL AG | Sponsored ADR | 45780Q103 | 6,290 | 502,422 | SH | SOLE | 502,422 | 0 | 0 | ||
ISHARES RUSSELL 2000 ETF | Put | 464287655 | 4,979 | 1,280,000 | SH | Put | SOLE | 1,280,000 | 0 | 0 | |
KITE PHARMA INC. | Common | 49803L109 | 86 | 18,500 | SH | Put | SOLE | 18,500 | 0 | 0 | |
KITE PHARMA INC. | Common | 49803L109 | 27 | 7,500 | SH | Put | SOLE | 7,500 | 0 | 0 | |
LA JOLLA PHARMACEUTICAL CO. | Common | 503459604 | 22,351 | 804,299 | SH | SOLE | 804,299 | 0 | 0 | ||
LION BIOTECHNOLOGIES INC | Common | 53619R102 | 18,322 | 3,180,913 | SH | SOLE | 3,180,913 | 0 | 0 | ||
MIRATI THERAPEUTICS INC. | Common | 60468T105 | 50,014 | 1,453,055 | SH | SOLE | 1,453,055 | 0 | 0 | ||
NANTKWEST- INC | Common | 63016Q102 | 7,301 | 728,887 | SH | SOLE | 728,887 | 0 | 0 | ||
NEURODERM LTD. | Common | M74231107 | 22,801 | 1,103,093 | SH | SOLE | 1,103,093 | 0 | 0 | ||
ONCOTHYREON INC | Common | 682324108 | 15,088 | 5,506,618 | SH | SOLE | 5,506,618 | 0 | 0 | ||
PERNIX THERAPEUTICS HOLDINGS | Common | 71426V108 | 18,974 | 6,004,564 | SH | SOLE | 6,004,564 | 0 | 0 | ||
SAREPTA THERAPEUTICS -INC | Common | 803607100 | 15,060 | 469,025 | SH | SOLE | 469,025 | 0 | 0 | ||
SAREPTA THERAPEUTICS -INC | Common | 803607100 | 1,179 | 170,800 | SH | Call | SOLE | 170,800 | 0 | 0 | |
SAREPTA THERAPEUTICS -INC | Common | 803607100 | 58 | 7,500 | SH | Call | SOLE | 7,500 | 0 | 0 | |
SORRENTO THERAPEUTICS INC | Common | 83587F202 | 18,051 | 2,151,437 | SH | SOLE | 2,151,437 | 0 | 0 | ||
SPECTRUM PHARMACEUTICALS INC | Common | 84763A108 | 7,867 | 1,315,600 | SH | SOLE | 1,315,600 | 0 | 0 | ||
TONIX PHARMACEUTICALS HLDG | Common | 890260201 | 2,170 | 410,300 | SH | SOLE | 410,300 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 3,351 | 255,097 | SH | SOLE | 255,097 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | Common | 921659108 | 23,965 | 2,124,593 | SH | SOLE | 2,124,593 | 0 | 0 | ||
VERACYTE INC | Common | 92337F107 | 3,622 | 772,297 | SH | SOLE | 772,297 | 0 | 0 | ||
VERICEL CORP. | Common | 92346J108 | 3,076 | 1,135,120 | SH | SOLE | 1,135,120 | 0 | 0 |